Login

Cart

Your cart is empty

Potential health and safety risks of 3D resins

Photopolymer resins are reactive manufacturing materials. “Monomer-free” describes a formulation characteristic as supplied and does not by itself establish universal safety, biocompatibility or absence of hazard. The hazard profile of each material as supplied is described in the applicable SDS. Final-part safety and biological suitability depend on the complete material–process–application system, including Product/version, printer, exposure, washing, post-curing, geometry and intended use. potential health problems of monomer based 3D resins

3Dresyns offers different resin systems for biomedical, orthodontic and dental development workflows. Any safety or biological-evaluation statement must be specific to the Product/version, documented processing conditions, endpoint and intended use; no universal safety claim is inferred from chemistry alone.

Some resins have hazard classifications or handling requirements as supplied. Appropriate printing and post-processing can influence residuals and final-part performance, but risk should not be assumed to be completely eliminated without the relevant evidence and validation.

Health, safety and biological-response considerations depend on both formulation and workflow. Polymer conversion, cleaning, post-curing, contamination control, specimen geometry and intended use can all affect residual constituents and final-part performance.

Depending on formulation and processing, printed photopolymers may contain residual constituents, reaction by-products, extractables or leachables. Where these are relevant to the application, they should be controlled and evaluated using appropriate process and analytical methods.

The SDS describes hazards of the liquid material as supplied. It should not be used as a proxy for the biological response or regulatory status of a finished printed part; those outcomes require application- and workflow-specific validation.

This matter is particularly of great concern in biomedical applications where 3D printed materials are in direct contact with the human body, such as the mouth in dental applications.

Why can materials described as “biocompatible” still require careful printing, cleaning and post-processing?

Applicable residual-monomer, extractables and biological-evaluation requirements depend on the specific material, device, intended use, jurisdiction and test method. FDA guidance and standards such as ISO 10993, ISO 13485 or dental-material standards do not establish a single universal residual-monomer limit for all printed devices. Additives and process auxiliaries, including Fine Tuners, must be included in the composition/process assessment when they are used.

Which is the risk of trapped residual monomers and other chemicals in printed devices for human health?
The answer depends on the type and concentration of physically trapped monomers and other leachables and extractables in the medical devices.

For more info read:

How can the risks for humans be figured out?

Review the SDS for hazards and safe handling of the material as supplied. For a finished device or part, use the relevant process records, analytical data, biological-evaluation evidence and application-specific risk assessment rather than assuming that uncured-ingredient hazards directly represent final-part exposure.

Materials for biological-evaluation workflows

Discover 3Dresyns material options designed to support biological-evaluation requirements after appropriate printing and post-processing:

Regulatory and standards context may include FDA, ISO13485 and ISO10993. Applicability depends on the specific device, intended use, jurisdiction, organisation, endpoint and evidence scope; these references do not establish portfolio-wide compliance, certification or approval.
Monomer-free (as supplied) systems are formulation options. Extractables, leachables, residuals and biological response must be evaluated for the specific Product/version, printed specimen and workflow; no general superiority to monomer-based systems is assumed without like-for-like evidence.
3Dresyns develops materials and process workflows for biomedical-development applications. Final safety, biological suitability and regulatory compliance depend on the specific Product, complete manufacturing process, intended use and device-manufacturer validation.

Customisation

3Dresyns custom-designs resin systems, post-processing protocols and quality controls for biomedical, food-contact and other regulated-development workflows. Final safety, biological suitability and regulatory compliance must be validated for the specific Product, process and finished application. custom

    You may contact us to discuss customisation services for synthetic, bio-based and biological-evaluation-oriented 3Dresyns and your specific performance goals at: info@3Dresyns.com

    Learn more about Certification of biomedical devices and food packaging

    From prototyping to industrial production, performance depends on materials, calibration and process control